https://www.marketscreener.com/quote/stock/BARINTHUS-BIOTHERAPEUTICS-122186771/news/Vaccitech-to-Present-Positive-Final-Data-at-EASL-Congress-for-Phase-1b-2-HBV002-Study-in-Adults-with-44158847/?utm_source=telegram&utm_medium=social&utm_campaign=share